University of California San Diego researchers found that a post-COVID lung disease shares origins with other scarring lung diseases, which may offer a path to effective therapies, according to a study released Wednesday, July 20.Although most people recover relatively quickly from COVID-19, around one-third of survivors experience symptoms weeks and months after the initial infection. In the study published in Wednesday’s online issue of eBioMedicine, however, UCSD scientists studied interstitial lung disease, a form of “long COVID” that consists of a group of chronic pulmonary disorders characterized by inflammation and lung scarring.The researchers said little is currently known about interstitial lung disease – which can be fatal without a lung transplant in its most se
